dobutamine has been researched along with natriuretic peptide, brain in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.52) | 18.2507 |
| 2000's | 45 (68.18) | 29.6817 |
| 2010's | 19 (28.79) | 24.3611 |
| 2020's | 1 (1.52) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, YL; Furuno, T; Hitomi, N; Kitaoka, H; Takata, J | 1 |
| Aronson, D; Burger, AJ | 3 |
| Burnett, JC; Hahn, EL; Hart, CY; Meyer, DM; Redfield, MM | 1 |
| Aronson, D; Burger, AJ; Elkayam, U; Ghali, J; Haught, H; Horton, DP; Neibaur, MT | 1 |
| Elkayam, U; Ghali, JK; Horton, DP; Silver, MA | 1 |
| Burger, AJ; Cheng, ML; Dennish, G; Dinerman, J; Elkayam, U; Ghali, JK; Horton, DP; Koren, M; LeJemtel, T; Silver, M; Torre, G | 1 |
| Gattis, WA; Gheorghiade, M; Jain, P; Klein, L; Massie, BM | 1 |
| Adams, KF; Gheorghiade, M; Mathur, VS | 1 |
| Adams, KF; Gattis, WA; Gheorghiade, M; Jaffe, AS; O'Connor, CM | 1 |
| Aronson, D; Burger, AJ; Burger, MR; Horton, DP | 1 |
| Aranda, JM; Hill, JA; Hsu, K; Pauly, DF; Schofield, R | 1 |
| Dodge-Khatami, A; Hirsch, A; Mulder, BJ; Stoker, J; Tulevski, II; van der Wall, EE | 1 |
| Burger, AJ; Ciesla, G; de Lissovoy, G; Munger, M; Stier, DM | 1 |
| Burger, AJ; Silver, MA | 1 |
| Asada, J; Iwasaka, T; Lauer, MS; Thomas, JD; Tsuji, H | 1 |
| Sharma, M; Teerlink, JR | 1 |
| Hausmann, H; Hennig, F; Hetzer, R; Lehmkuhl, HB; Potapov, EV; Sodian, R; Volk, HD; Wagner, FD | 1 |
| Andreadou, I; Androulakis, A; Avgeropoulou, C; Demopoulou, M; Kallikazaros, I; Markantonis-Kyroudis, S; Missovoulos, P | 1 |
| Abraham, WT; Adams, KF; Berkowitz, RL; Cheng, ML; Costanzo, MR; Fonarow, GC; LeJemtel, TH; Wynne, J | 1 |
| Dec, GW | 1 |
| Gortney, JS; Porter, KB | 1 |
| Burger, AJ | 1 |
| Adams, KF; Gattis Stough, W; Gheorghiade, M; Hasselblad, V; Jaffe, AS; O'Connor, CM | 1 |
| Bo Hansen, A; Egstrup, K; Husic, M; Møller, JE; Nørager, B; Pellikka, PA | 1 |
| Gerhard, T; Hartzema, AG; Winterstein, AG; Zineh, I | 1 |
| Atar, D; Hodt, A; Steine, K | 1 |
| Adamopoulos, S; Farmakis, D; Filippatos, GS; Gheorghiade, M; Iliodromitis, EK; Karatzas, D; Kremastinos, DT; Paraskevaidis, I; Parissis, JT; Tsiapras, D | 1 |
| Arnold, LM; Carroll, NV; Crouch, MA; Oinonen, MJ | 1 |
| Bax, JJ; Boersma, E; de Jonge, R; Dunkelgrun, M; Elhendy, A; Feringa, HH; Karagiannis, SE; Poldermans, D; Schouten, O; Vidakovic, R | 1 |
| Kurien, S; Miller, WL; Warfield, KT; Wood, CM | 1 |
| Cohen-Solal, A; Kivikko, M; Kleber, FX; Mebazaa, A; Nieminen, MS; Packer, M; Padley, RJ; Pocock, SJ; Põder, P; Thakkar, R | 1 |
| Barr, M; Bourge, RC; Jessup, ML; Lilly-Hersley, J; Linde, P; Mancini, D; McCluskey, T; Mehra, MR; Radovancevic, B; Rayburn, B; Taylor, DO | 1 |
| Askovich, B; Berry, JG; Cowley, CG; Hawkins, JA; Shaddy, RE | 1 |
| Butler, J; Giamouzis, G; Giannakoulas, G | 1 |
| Ata, N; Birdane, A; Cavusoglu, Y; Demirustu, C; Gorenek, B; Tek, M; Timuralp, B; Unalir, A | 1 |
| Haritakis, CN; Nyktari, EG; Parthenakis, FI; Patrianakos, AP; Vardas, PE; Zacharis, EA | 1 |
| Agha, SA; Butler, J; Georgiopoulou, V; Giamouzis, G; Giannakoulas, G; Kalogeropoulos, A; Karvounis, H; Tsarpalis, K | 1 |
| Celik, T; Iyisoy, A; Kardesoglu, E; Yuksel, UC | 1 |
| Brugaletta, S; Comerci, G; Di Giannuario, G; Forni, F; Lombardo, A; Loperfido, F; Lotrionte, M; Marchese, N; Natali, R; Pisanello, C; Savino, M; Vigna, C | 1 |
| Bistola, V; Filippatos, G; Ikonomidis, I; Kremastinos, DT; Papadopoulos, C; Paraskevaidis, IA; Parissis, JT | 1 |
| Donati, A; Elisei, D; Falzetti, G; Pelaia, P; Principi, T | 1 |
| Mebazaa, A; Paraskevaidis, I; Parissis, JT; Rafouli-Stergiou, P | 1 |
| Eicken, A; Hess, J; Kühn, A; Vogel, M; Vogt, M; Wiese, J | 1 |
| Cai, D; Cohen-Solal, A; Huang, B; Logeart, D; Mebazaa, A; Nieminen, MS | 1 |
| Bertoletti, L; Humbert, M; Jaïs, X; Price, LC; Simonneau, G; Sitbon, O; Souza, R; Sztrymf, B | 1 |
| Bombardini, T; Ciampi, Q; Della Porta, M; Petruzziello, B; Picano, E; Pratali, L; Sicari, R; Villari, B | 1 |
| Andersson, B; Bergh, CH; Dahlström, U; Forfang, K; Kivikko, M; Sarapohja, T; Ullman, B; Wikström, G | 1 |
| Ciria, R; De la Mata, M; Muñoz-Villanueva, MC; Muntane, J; Padillo, J; Rioja, P; Sitges-Serra, A; Solórzano, G; Vallejo, JA | 1 |
| Bensch, R; Berghoefer, G; Kraemer, J; Mut, H; Rudolph, A; Scheiner, S; Schimke, I; Schulz, O; Schulz-Menger, J | 1 |
| Coons, JC; McGraw, M; Murali, S | 1 |
| Anastasiou-Nana, M; Bistola, V; Ikonomidis, I; Papadopoulos, C; Paraskevaidis, IA; Parissis, J; Stassinos, V | 1 |
| Blotta, MH; Fernandes, JL; Ganem, F; Hueb, WA; Nicolau, JC; Ramires, JA; Serrano, CV; Souza, JA | 1 |
| Burger, AJ; Josephson, ME; Mittleman, MA; Nearing, BD; Verrier, RL; Wellenius, GA | 1 |
| Allouche, S; Gérard, JL; Hanouz, JL; Lemoine, S; Valette, X | 1 |
| Matunović, R; Spasojević Kosić, L; Trailović, DR | 1 |
| Campbell, V; Pemberton, CJ; Richards, AM; Siriwardena, M | 1 |
| Bartko, PE; Baumgartner, H; Bergler-Klein, J; Burwash, IG; Clavel, MA; Dumesnil, JG; Graf, S; Heinze, G; Khorsand, A; Mundigler, G; Pibarot, P; Rosenhek, R; Sénéchal, M | 1 |
| Gu, Y; Niu, HY; Pan, HY; Pan, M; Yu, XH; Zhu, JH | 1 |
| Barretto, AC; Brancalhão, EC; Cardoso, JN; Ochiai, ME; Oliveira, MT; Puig, RS; Vieira, KR | 1 |
| Akturk, IF; Birant, A; Erturk, M; Karakurt, H; Kurtar Mansıroglu, A; Oner, E; Somuncu, MU; Uzun, F; Yalcin, AA; Yildirim, A | 1 |
| Chivite, D; Corbella, X; Formiga, F | 1 |
| Shan, YX; Wang, XC; Zhu, DM | 1 |
| Hu, MH; Ji, CL; Lai, ZZ; Meng, JB; Tian, S; Xu, XJ; Zhang, G | 1 |
| Chen, X; Lei, J; Liao, X; Qian, L; Zhang, S | 1 |
9 review(s) available for dobutamine and natriuretic peptide, brain
| Article | Year |
|---|---|
Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
Topics: Aged; Diuretics; Dobutamine; Enalaprilat; Female; Heart Failure; Hemodynamics; Hospitalization; Humans; Hydrazones; Injections, Intravenous; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Pulmonary Wedge Pressure; Pyridazines; Renal Agents; Simendan; Vasodilator Agents | 2003 |
B-type natriuretic peptide: from bench to bedside.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiotonic Agents; Diuretics; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Randomized Controlled Trials as Topic; Receptors, Atrial Natriuretic Factor; Vasodilator Agents | 2003 |
Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure.
Topics: Acute Disease; Age Distribution; Aged; Cardiotonic Agents; Dobutamine; Drug Costs; Female; Heart Failure; Hospital Costs; Humans; Life Expectancy; Male; Middle Aged; Models, Econometric; Monte Carlo Method; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Admission; Predictive Value of Tests; Sex Distribution; Survival Analysis; Treatment Outcome; United States; Value of Life | 2003 |
A rational approach for the treatment of acute heart failure: current strategies and future options.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins | 2004 |
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Diuretics; Dobutamine; Furosemide; Heart Failure; Humans; Hydrazones; Isosorbide Dinitrate; Natriuretic Agents; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Pyridazines; Simendan; Vasodilator Agents | 2006 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Milrinone; Morphine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Practice Guidelines as Topic; Vasodilator Agents | 2011 |
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan | 2014 |
Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
Topics: Acute Disease; Cardiotonic Agents; Cohort Studies; Dobutamine; Heart Failure; Hospital Mortality; Humans; Natriuretic Peptide, Brain; Patient Readmission; Survival Analysis | 2015 |
Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
Topics: Aged; Disease Progression; Dobutamine; Dopamine; Epinephrine; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Network Meta-Analysis; Norepinephrine; Patient Safety; Recombinant Proteins; Shock, Cardiogenic; Simendan; Treatment Outcome | 2020 |
20 trial(s) available for dobutamine and natriuretic peptide, brain
| Article | Year |
|---|---|
Effect of diabetes mellitus on heart rate variability in patients with congestive heart failure.
Topics: Atrial Natriuretic Factor; Cardiotonic Agents; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Signal Processing, Computer-Assisted | 2001 |
Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
Topics: Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Natriuretic Peptide, Brain; Statistics, Nonparametric; Tachycardia, Ventricular; Treatment Outcome | 2001 |
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cardiotonic Agents; Dobutamine; Female; Health Care Costs; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Readmission; Prospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2002 |
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Topics: Aged; Cardiotonic Agents; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Tachycardia, Ventricular | 2002 |
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Double-Blind Method; Endpoint Determination; Heart Failure; Hospitalization; Humans; Multicenter Studies as Topic; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Pilot Projects; Randomized Controlled Trials as Topic; Troponin I; Troponin T | 2003 |
Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin.
Topics: Arrhythmias, Cardiac; Cardiotonic Agents; Cytokines; Dobutamine; Electrocardiography, Ambulatory; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Natriuretic Agents; Natriuretic Peptide, Brain; Neurotransmitter Agents; Ventricular Premature Complexes | 2003 |
Comparison of the effects of dobutamine and nesiritide (B-type natriuretic peptide) on ventricular ectopy in acutely decompensated ischemic versus nonischemic cardiomyopathy.
Topics: Aged; Arrhythmias, Cardiac; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Agents; Natriuretic Peptide, Brain; Prospective Studies; Treatment Outcome; Ventricular Premature Complexes | 2003 |
Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Sympathomimetics | 2004 |
The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Malondialdehyde; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Pyridazines; Simendan; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
Topics: Cardiotonic Agents; Cost-Benefit Analysis; Decision Trees; Dobutamine; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Models, Economic; Models, Statistical; Monte Carlo Method; Natriuretic Agents; Natriuretic Peptide, Brain | 2006 |
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Topics: Aged; Apoptosis; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography; Fas Ligand Protein; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Membrane Glycoproteins; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors | 2006 |
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Analysis | 2007 |
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Topics: Cardiotonic Agents; Dobutamine; Double-Blind Method; Echocardiography; Eligibility Determination; Heart Failure; Heart Transplantation; Humans; Infusions, Intravenous; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Preoperative Care; Research Design; Sample Size; Severity of Illness Index; Survival Rate; Treatment Outcome | 2007 |
Behavior of B-type natriuretic peptide during mechanical ventilation and spontaneous breathing after extubation.
Topics: Adult; Aged; Biomarkers; Cell Size; Critical Illness; Dobutamine; Dyspnea; Female; Heart Failure; Humans; Intensive Care Units; Male; Middle Aged; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Respiration, Artificial; Sensitivity and Specificity; Ventilator Weaning; Ventricular Dysfunction, Left; Water-Electrolyte Balance | 2009 |
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Antihypertensive Agents; Cardiotonic Agents; Confidence Intervals; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Myocardial Perfusion Imaging; Natriuretic Peptide, Brain; Odds Ratio; Perfusion; Pulmonary Wedge Pressure; Pyridazines; Simendan; Vasodilator Agents | 2010 |
Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure.
Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Prognosis; Prospective Studies; Tachycardia, Ventricular | 2012 |
Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Blood Pressure; Cardiotonic Agents; China; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Recombinant Proteins; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2014 |
Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Dobutamine; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Time Factors; Treatment Outcome | 2014 |
Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
Topics: Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Pyridazines; Recovery of Function; Simendan; Stroke Volume; Systole; Time Factors; Treatment Outcome; Turkey; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.
Topics: Biomarkers; Demography; Dobutamine; Fatty Acid-Binding Proteins; Female; Hemodynamics; Humans; Hydrazones; Lactic Acid; Male; Middle Aged; Multivariate Analysis; Myocardium; Natriuretic Peptide, Brain; Pyridazines; Regression Analysis; Shock, Septic; Simendan; Troponin I; Ventricular Function, Left | 2016 |
37 other study(ies) available for dobutamine and natriuretic peptide, brain
| Article | Year |
|---|---|
Natriuretic peptides and contractile reserve in dilated cardiomyopathy.
Topics: Atrial Natriuretic Factor; Cardiac Catheterization; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Female; Humans; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain | 1998 |
Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
Topics: Adrenergic beta-Agonists; Animals; Cyclic GMP; Diastole; Dobutamine; Dogs; Drug Synergism; Heart; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Nitric Oxide; Reference Values; Second Messenger Systems; Systole; Ventricular Function, Left | 2001 |
Sustained use of nesiritide to aid in bridging to heart transplant.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Preoperative Care; Time Factors; Treatment Outcome; Waiting Lists | 2003 |
Effect of pulmonary valve regurgitation on right ventricular function in patients with chronic right ventricular pressure overload.
Topics: Adult; Cardiotonic Agents; Dobutamine; Female; Humans; Hypertension, Pulmonary; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Natriuretic Peptide, Brain; Pulmonary Valve Insufficiency; Pulmonary Valve Stenosis; Stroke Volume; Tetralogy of Fallot; Ventricular Function, Right; Ventricular Pressure | 2003 |
Nesiritide in acute heart failure.
Topics: Acute Disease; Cardiac Output, Low; Clinical Trials as Topic; Comorbidity; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Treatment Outcome | 2003 |
Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia.
Topics: Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Double-Blind Method; Echocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Pilot Projects; Predictive Value of Tests; Severity of Illness Index | 2004 |
Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Dobutamine; Dopamine; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; Enoximone; Epidemiologic Methods; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptides; Nerve Tissue Proteins; Norepinephrine; Peptide Fragments; Prognosis; Shock, Cardiogenic | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Outcome | 2005 |
Risk of death with nesiritide.
Topics: Adrenergic beta-Antagonists; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain | 2005 |
Risk of death with nesiritide.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Research Design | 2005 |
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
Topics: Adrenergic beta-Agonists; Aged; Biomarkers; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Agents; Natriuretic Peptide, Brain; Pilot Projects; Predictive Value of Tests; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Troponin I; Troponin T | 2005 |
Changes in the Doppler myocardial performance index during dobutamine echocardiography: association with neurohormonal activation and prognosis after acute myocardial infarction.
Topics: Aged; Anti-Arrhythmia Agents; Atropine; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Combinations; Echocardiography, Doppler; Echocardiography, Stress; Female; Humans; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Observer Variation; Peptide Fragments; Prognosis; Prospective Studies; Survival Analysis; Systole; Ventricular Dysfunction, Left | 2006 |
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Health Care Costs; Heart Failure; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Odds Ratio; Patient Readmission; Regression Analysis; Retrospective Studies; Treatment Outcome | 2006 |
Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
Topics: Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; ROC Curve; Survival Rate; Time Factors | 2007 |
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Topics: Aged; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Survival Rate; Urine | 2006 |
Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease.
Topics: Cardiotonic Agents; Dobutamine; Female; Fontan Procedure; Heart Bypass, Right; Heart Defects, Congenital; Heart Ventricles; Humans; Infant; Length of Stay; Male; Milrinone; Multivariate Analysis; Natriuretic Peptide, Brain; Palliative Care; Postoperative Period; Prognosis; Prospective Studies | 2008 |
A struggle to SURVIVE: to abandon or not to abandon levosimendan?
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Rate; Treatment Outcome | 2007 |
Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine.
Topics: Dobutamine; Humans; Hydrazones; Natriuretic Peptide, Brain; Neurotransmitter Agents; Peptide Fragments; Protein Precursors; Pyridazines; Simendan; Treatment Outcome | 2008 |
NT-proBNP response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Peptide Fragments | 2008 |
Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Pyridazines; Simendan; Time Factors | 2008 |
The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Pyridazines; Simendan; Time Factors | 2008 |
Prediction of functional capacity by low-dose dobutamine stress echocardiography in chronic heart failure.
Topics: Adrenergic beta-Agonists; Aged; Chronic Disease; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Prospective Studies; Respiratory Function Tests; Ventricular Dysfunction, Left | 2008 |
Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Heart Ventricles; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Severity of Illness Index; Simendan; Stroke Volume | 2008 |
Levosimendan: from basic science to clinical practice.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Kidney; Myocardial Contraction; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Quality of Life; Simendan; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Right | 2009 |
Reduced contractile reserve of the systemic right ventricle under Dobutamine stress is associated with increased brain natriuretic peptide levels in patients with complete transposition after atrial repair.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Echocardiography, Transesophageal; Female; Humans; Linear Models; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Transposition of Great Vessels; Ventricular Dysfunction, Right; Young Adult | 2009 |
Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Randomized Controlled Trials as Topic; Retrospective Studies; Simendan | 2009 |
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Pressure; C-Reactive Protein; Cardiotonic Agents; Creatinine; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hypertension, Pulmonary; Intensive Care Units; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Sodium; Survival Analysis; Vasoconstrictor Agents; Young Adult | 2010 |
Pressure-volume relationship during dobutamine stress echocardiography predicts exercise tolerance in patients with congestive heart failure.
Topics: Aged; Blood Pressure; Dobutamine; Echocardiography; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Stroke Volume; Vasodilator Agents | 2010 |
BNP as marker of heart dysfunction in patients with liver cirrhosis.
Topics: Adult; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Dobutamine; Female; Heart Diseases; Heart Rate; Humans; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Predictive Value of Tests; Prospective Studies; Radionuclide Ventriculography; Severity of Illness Index; Spain; Stroke Volume | 2010 |
Influence of acute and chronic myocardial loading conditions, function, structural changes and extracardiac factors on NT-proBNP in asymptomatic patients with preserved ejection fraction.
Topics: Acute Disease; Aged; Biomarkers; Chronic Disease; Dobutamine; Exercise Test; Female; Fibrosis; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2011 |
Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure.
Topics: Aged; Atrial Function, Left; Biomarkers; Chronic Disease; Dobutamine; Echocardiography; Echocardiography, Stress; Female; Forecasting; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Pyridazines; Simendan; Treatment Outcome | 2012 |
Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery.
Topics: Acrylamides; Aged; beta-Alanine; Biomarkers; Brazil; C-Reactive Protein; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Female; Hospital Mortality; Humans; Inflammation; Inflammation Mediators; Intensive Care Units; Interleukin-6; Interleukin-8; Intra-Aortic Balloon Pumping; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; P-Selectin; Postoperative Complications; Respiration, Artificial; Risk Assessment; Risk Factors; ROC Curve; Time Factors; Treatment Outcome | 2011 |
Effect of lipopolysaccharide, cytokines, and catecholamines on brain natriuretic peptide release from human myocardium.
Topics: Aged; Atrial Appendage; Catecholamines; Comorbidity; Cytokines; Dobutamine; Endothelin-1; Epinephrine; Female; Humans; In Vitro Techniques; Interleukin-1beta; Lipopolysaccharides; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Random Allocation; Tumor Necrosis Factor-alpha | 2012 |
Resting and dobutamine stress test induced serum concentrations of brain natriuretic peptide in German Shepherd dogs.
Topics: Aging; Animals; Brain; Cardiotonic Agents; Dobutamine; Dogs; Echocardiography, Stress; Female; Gene Expression Regulation; Male; Natriuretic Peptide, Brain | 2012 |
Cardiac biomarker responses to dobutamine stress echocardiography in healthy volunteers and patients with coronary artery disease.
Topics: Biomarkers; Case-Control Studies; Coronary Artery Disease; Dobutamine; Echocardiography, Stress; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Protein Sorting Signals; Troponin T | 2012 |
Two-dimensional strain for the assessment of left ventricular function in low flow-low gradient aortic stenosis, relationship to hemodynamics, and outcome: a substudy of the multicenter TOPAS study.
Topics: Adrenergic Agonists; Aged; Aged, 80 and over; Aortic Valve Stenosis; Biomarkers; Chi-Square Distribution; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Female; Heart Ventricles; Hemodynamics; Humans; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Multivariate Analysis; Myocardial Contraction; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Severity of Illness Index; Stress, Mechanical; Stroke Volume; Survival Rate; Time Factors; Ventricular Function, Left | 2013 |